News Quantified

RFL – rafael holdings, inc. class b (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Rafael Holdings GAAP EPS of $0.19, revenue of $0.24M [Seeking Alpha]

Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results [Yahoo! Finance]

Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results

Rafael (NYSE:RFL) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results

Form 4 Rafael Holdings, Inc. For: Dec 21 Filed by: Polinsky David

Form 4 Rafael Holdings, Inc. For: Dec 13 Filed by: JONAS HOWARD S

Form 10-Q Rafael Holdings, Inc. For: Oct 31

Form 8-K Rafael Holdings, Inc. For: Dec 11

Form 25-NSE Rafael Holdings, Inc. Filed by: NYSE AMERICAN LLC

Top News Gainers

3/24 Rafael Pharmaceuticals Enrolls More Than 75% of Patients Needed for Pivotal Phase 3 Trial (AVENGER 500) of CPI-613®? (devimistat) for Patients with Metastatic Pancreatic Cancer 18.1%

4/28 MD Anderson Cancer Center Now Enrolling Patients in Rafael Pharmaceuticals’ Phase 2 Clinical Trial of CPI-613® (devimistat) for Relapsed or Refractory Burkitt’s Lymphoma/Leukemia 13.6%

6/25 Rafael Pharmaceuticals Enters into Out-Licensing Agreement with Ono Pharmaceutical to Accelerate Clinical Development and Commercialization of Cancer Drug Candidate CPI-613® (devimistat) in Japan and Other Asian Countries 9.7%

12/5 Rafael Holdings to Present at LD Micro Main Event 9.3%

1/23 LipoMedix Announces Publication of Positive Phase 1 Data for Promitil® (PL-MLP) in Research Journal Investigational New Drugs 9.0%

11/21 Form DEF 14A Rafael Holdings, Inc. For: Jan 15 6.5%

12/3 Data on Rafael Pharmaceuticals’ CPI-613® (devimistat) in Patients with Relapsed Burkitt Lymphoma to be Presented at the 2019 American Society of Hematology (ASH) Annual Meeting & Exposition 6.4%

1/13 Rafael Pharmaceuticals to Present at 38th Annual J.P. Morgan Healthcare Conference 4.2%

9/24 Form 4 Rafael Holdings, Inc. For: Sep 23 Filed by: Polinsky David 4.0%

5/16 Sanjeev Luther, President and CEO of Rafael Pharmaceuticals, to be Honored by American Cancer Society at Annual Starry Night Gala 3.4%

Top News Decliners

9/17 Rafael Pharmaceuticals Announces Expansion into France of Pivotal Phase 3 Trial (AVENGER 500) of CPI-613®? (devimistat) in Combination with Modified FOLFIRINOX as First-Line Treatment for Patients with Metastatic Pancreatic Cancer -6.7%

8/8 Form 8-K Rafael Holdings, Inc. For: Aug 07 -6.3%

3/3 Rafael Pharmaceuticals Appoints Sanjay Sehgal, Ph.D., to Chief Regulatory Affairs and Quality Assurance Officer -5.9%

5/13 Rafael Pharmaceuticals Appoints Senior Vice President for Clinical Development and Operations -5.5%

11/7 Rafael Pharmaceuticals Joins the Pancreatic Cancer Action Network’s Scientific & Medical Affairs Industry Membership -5.0%

3/5 Rafael Holdings Reports Second Quarter Fiscal Year 2020 Results -4.8%

9/26 Form 8-K Rafael Holdings, Inc. For: Sep 23 -4.4%

12/9 Form 8-K Rafael Holdings, Inc. For: Dec 09 -4.2%

4/22 Form 4 Rafael Holdings, Inc. For: Apr 20 Filed by: JONAS HOWARD S -3.8%

10/2 Rafael Pharmaceuticals Appoints Wendy McDermott to Chief People Officer -3.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day